Literature DB >> 11228184

Strict volume control normalizes hypertension in peritoneal dialysis patients.

A I Günal1, S Duman, M Ozkahya, H Töz, G Asçi, F Akçiçek, A Basçi.   

Abstract

The aim of this study is to investigate whether normal blood pressure (BP) can be achieved in patients with hypertension on continuous ambulatory peritoneal dialysis (CAPD) therapy by strict volume control without the use of antihypertensive drugs. Of the 78 patients in our center, 47 persons had hypertension and/or were on antihypertensive drug therapy. After discontinuing these drugs, a strong dietary salt restriction was imposed by repeatedly explaining the need for it to patients and families. If this approach did not result in sufficient BP decrease, ultrafiltration (UF) was added by increased use of hypertonic (3.86% glucose) peritoneal dialysis solution. Cardiothoracic index (CTI) on the chest radiograph was also used as a measure of volume control. With salt restriction alone or combined with UF, body weight decreased by a mean of 2.8 +/- 0.5 kg, and BP decreased from a mean of 158.2 +/- 17.0/95.7 +/- 10.3 to 119.7 +/- 16.0/77.9 +/- 9.7 mm Hg in 37 patients, accompanied by a decrease in CTI from 48.0% +/- 5.6% to 42.9% +/- 4.5%. In 19 patients who had residual renal function, 24-hour urine volume decreased to 28% of the pretreatment volume, accompanied by a mean decrease in Kt/V urea from 2.06 +/- 0.5 to 1.85 +/- 0.4. In 7 of the remaining patients who did not respond to the applied treatment, BP decreased from 158.8 +/- 23.2/111.6 +/- 9.8 to 113.5 +/- 14.3/76.4 +/- 6.2 mm Hg after administration of an angiotensin-converting enzyme (ACE) inhibitor. Their CTI was 41.2% +/- 1.3%, indicating the absence of hypervolemia. In 3 patients, the desired results could not be reached because of noncompliance. Our findings show that normal BP can be achieved by severe salt restriction combined with increased UF in the majority of CAPD patients. This is accompanied by a decrease in CTI from upper limits into the normal range, but also by a decrease in residual renal function and Kt/V index. In most of the remaining patients, normal BP can be reached by the use of ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228184

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  27 in total

Review 1.  Sodium and volume overload in peritoneal dialysis: limitations of current treatment and possible solutions.

Authors:  Mukesh Khandelwal; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

2.  The ISPD Cardiovascular and Metabolic Guideline for Adults Treated with Peritoneal Dialysis.

Authors:  Martin Wilkie
Journal:  Perit Dial Int       Date:  2015 Jul-Aug       Impact factor: 1.756

Review 3.  [Peritoneal dialysis--an ideal initial dialysis mode].

Authors:  Heidi Puttinger
Journal:  Wien Med Wochenschr       Date:  2013-07-02

4.  Volume control in diabetic and nondiabetic peritoneal dialysis patients.

Authors:  Hong-bing Gan; Meng-hua Chen; Bengt Lindholm; Tao Wang
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 5.  The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Authors:  Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-17       Impact factor: 8.237

6.  A Patient on Peritoneal Dialysis with Refractory Volume Overload.

Authors:  Martin Wilkie
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 8.237

Review 7.  Obstructive sleep apnea and hypertension: is the primary link simply volume overload?

Authors:  Jonathan Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 8.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

9.  Resistant hypertension and obstructive sleep apnea in the setting of kidney disease.

Authors:  Khaled Abdel-Kader; Sheena Dohar; Nirav Shah; Manisha Jhamb; Steven E Reis; Patrick Strollo; Daniel Buysse; Mark L Unruh
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

10.  Extracellular volume expansion and the preservation of residual renal function in Korean peritoneal dialysis patients: a long-term follow up study.

Authors:  Harin Rhee; Min Ja Baek; Hyun Chul Chung; Jong Man Park; Woo Jin Jung; Soo Min Park; Jang Won Lee; Min Ji Shin; Il Young Kim; Sang Heon Song; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Eun Young Seong
Journal:  Clin Exp Nephrol       Date:  2015-11-26       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.